Atlas Trials

ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD)

Clinical trial NCT03362190 · COMPLETED

Trial details

NCT number
NCT03362190
Sponsor
Ophthotech Corporation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2017-10-11
Primary completion
2018-10-18
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.